In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3190-70-3, name is (S)-4-Isobutyloxazolidine-2,5-dione, introducing its new discovery. Formula: C7H11NO3
Urethane-protected amino acid-N-carboxyanhydrides
Urethane-protected NCAs and MTAs are prepared by reacting an NCA or NTA with a haloformate in an inert diluent, under anhydrous conditions and in the presence of a tertiary nitrogen-containing base having an atom or functional group sufficiently electron rich and positioned relative to the nitrogen of said base so as to render said atom or group capable of complexing with the H–N< group of said N-carboxyanhydride or N-thiocarboxyanhydride but able to generate N-carboxyanhydride or N-thiocarboxyanhydride anionic complexes capable of reacting with the haloformate. We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3190-70-3, and how the biochemistry of the body works.Formula: C7H11NO3
Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H1487NO – PubChem